Team

Charles ("Chip") N. Kahn, III

Mr. Kahn heads the Federation of American Hospitals, the national organization advocating for investor-owned hospitals and health systems.

Widely regarded as a leading authority on health policy and Medicare, his influence has earned him a spot on Modern Healthcare’s “100 Most Powerful People in Healthcare” list every year of his presidency. The Hill has recognized him among the capital's most effective association representatives for six straight years.

Mr. Kahn played a central role in the Robert Wood Johnson Foundation's initiative to unite major advocacy groups addressing health coverage for uninsured Americans.

Harvey C. Sigelbaum, Esq.

Mr. Sigelbaum brings his 30-year career as an insurance CEO to his current role as Senior Advisor at the Riverside Company. From 1996-2006, he guided MultiPlan, Inc. through significant growth as its president, co-CEO, vice chairman and executive chairman, establishing it as a major healthcare network organization. Previously, he spent 17 years at Amalgamated Life Insurance Company as president and CEO, after leading Urban Community Insurance Company, an "A"-rated New York regional insurer.

His extensive board leadership includes chairmanships of the National Cooperative Bank, National Cooperative Business Association, and National Association on Drug Abuse Problems. Mr. Sigelbaum has served on executive committees for America's Health Insurance Plans and the Council for Affordable Quality Healthcare, among numerous other industry organizations.

In 1994, President Clinton appointed him to federal service with Senate confirmation, and he was recently named to the Freedom from Hunger Ambassadors Council.

Howard Fillit, M.D.

Dr. Fillit established and directs both the Alzheimer's Drug Discovery Foundation and the Institute for the Study of Aging, philanthropic ventures accelerating drug development for Alzheimer's, dementia, and cognitive aging. With 25+ years in the field, he currently teaches as clinical professor of geriatrics, medicine, and neurobiology at Mount Sinai School of Medicine. Before founding ISOA, Dr. Fillit managed Medicare programs serving 125,000 members across eight regions at New York Life.

Fillet’s accomplishments include receiving the Alzheimer's Association's Rita Hayworth Award and authoring more than 200 scientific publications, including the authoritative Textbook of Geriatric Medicine and Gerontology. Dr. Fillit also provides expert consultation to pharmaceutical and biotechnology companies advancing treatments in this field.

Dan Dragalin, M.D.

Dr. Dragalin currently serves as the Medical Director at McKesson after his tenure as Chief Medical Officer at HIP (Health Insurance Plan of New York). Prior to joining HIP in 2007, he built and maintained MultiPlan's nationwide PPO network of 4,600 hospitals, 100,000 ancillary facilities, and more than 500,000 practitioners. His career spans executive roles at Great West Life, NYLCare, HMO Blue at Blue Cross/Blue Shield of New Jersey, and Prudential Insurance Company of America.

Dr. Dragalin has represented the Health Insurance Association of America on the AMA's CPT-4 Editorial Panel and served on the Physician Payment Review Commission's Coding Panel. His board experience includes the National Committee on Quality Assurance and technical committees for the Hospital Research and Educational Trust, Managed Health Care Association Task Force on Outcomes, and other key industry groups.

Jeffrey L. Cummings, M.D.

Dr. Cummings is the Joy Chambers-Grundy Professor of Brain Science and Director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada, Las Vegas (UNLV). His center focuses on accelerating clinical trials and therapeutic development for Alzheimer’s disease and other neurodegenerative conditions. A leader in dementia research, Dr. Cummings developed the Neuropsychiatric Inventory (NPI), a widely used tool for assessing behavioral symptoms in Alzheimer's and related disorders.

His training includes a neurology residency and behavioral neurology fellowship at Boston University, followed by specialized research in neuropathology and neuropsychiatry at London’s National Hospital for Nervous Diseases. Prior to joining UNLV, Dr. Cummings held faculty and leadership roles at UCLA and the Cleveland Clinic. He is a past president of both the Behavioral Neurology Society and the American Neuropsychiatric Association. Dr. Cummings has authored more than 900 peer-reviewed papers and 43 books.

Paula Tallal, Ph.D.

Dr. Tallal co-founded Scientific Learning Corporation (NASDAQ: SCIL) and has established herself as a world authority on language-learning disabilities. Both a cognitive neuroscientist and board-certified clinical psychologist, she co-directs the Center for Molecular and Behavioral Neuroscience at Rutgers University while serving on scientific advisory boards and government committees addressing language disorders and learning challenges.

With over two decades managing complex, multi-disciplinary federal research projects, Dr. Tallal has produced more than 150 publications and received top academic honors. Rutgers awarded her both their highest research distinction, the Board of Trustees Award for Excellence, and their highest faculty rank as Distinguished Professor II. Recently appointed as Board of Governors Professor of Neuroscience, Dr. Tallal holds several U.S. patents from her work with Scientific Learning Corporation, including innovations that earned the Thomas Alva Edison Patent Award in 2000.

Gene Huang

Mr. Huang brings over 30 years of leadership in healthcare services, with deep expertise in managed care, value-based care, and healthcare investment. He currently serves as Executive Chairman of ReferWell and CEO of CapZone Healthcare, focusing on healthcare innovation and access in underserved communities.

Previously, Mr. Huang led the post-acute business at Remedy Partners, advancing bundled payment programs across the U.S. His earlier roles include senior executive positions at Oxford Health Plans, CIGNA, Health Net, and Aveta, where he built one of the fastest-growing Medicare Advantage plans in the country.